Menu Menu

PLX    Protalix Biotherapeutics Inc    1006281    
Income Statement
Revenue plx-20241231x10k 17,959,000
Net Income plx-20241231x10k 3,236,000
Profit Margin 18.02%

Balance Sheet
Current Assets 47,853,000
Assets 61,563,000
Current Liabilities 24,220,000
Liabilities 29,126,000
Equity 32,437,000
Shares Out 73,543,000

Cash Flow Statement
Operating Cash Flow 4,683,000
Investing Cash Flow 19,541,000

Market Analysis
Market Cap 80,896,938
BVPS 0.44
PB 5.17
EPS -0.20
PS 1.13
FCF 24,224,000
Dividends
Jan Feb Mar
Apr May Jun
Jul Aug Sep
Oct Nov Dec

Earnings
Jan Feb Mar
3/14 0.15
Apr May Jun
5/10 -0.06
Jul Aug Sep
8/14 -0.03
Oct Nov Dec
11/14 0.04

Find a discrepancy? The most accurate way to find company fundamental data is to view PLX documents filed with the SEC.


PLX Filings       Clear



Find balance sheet, income statement, market analysis, and dividend information by typing the ticker symbol of a company.

Ticker:



View A List of Tickers





We can also help with your taxes.

Formal Tax

www.formal.tax





(402) 804-8293


Formal Financial App
Google Play - Apple Store

created using: Admin Canvas